AAAAAA
Results:
1-14
|
Results: 14
Authors:
Anaissie, EJ
Costa, SF
Citation: Ej. Anaissie et Sf. Costa, Nosocomial aspergillosis is waterborne, CLIN INF D, 33(9), 2001, pp. 1546-1548
Authors:
Uzon, O
Ascioglu, S
Anaissie, EJ
Rex, JH
Citation: O. Uzon et al., Risk factors and predictors of outcome in patients with cancer and breakthrough candidemia. (vol 32, pg 1713, 2001), CLIN INF D, 33(5), 2001, pp. 749-749
Authors:
Anaissie, EJ
Kuchar, RT
Rex, JH
Francesconi, A
Kasai, M
Muller, FMC
Lozano-Chiu, M
Summerbell, RC
Dignani, MC
Chanock, SJ
Walsh, TJ
Citation: Ej. Anaissie et al., Fusariosis associated with pathogenic Fusarium species colonization of a hospital water system: A new paradigm for the epidemiology of opportunistic mold infections, CLIN INF D, 33(11), 2001, pp. 1871-1878
Authors:
Rex, JH
Walsh, TJ
Nettleman, M
Anaissie, EJ
Bennett, JE
Bow, EJ
Carillo-Munoz, AJ
Chavanet, P
Cloud, GA
Denning, DW
de Pauw, BE
Edwards, JE
Hiemenz, JW
Kauffman, CA
Lopez-Berestein, G
Martino, P
Sobel, JD
Stevens, DA
Sylvester, R
Tollemar, J
Viscoli, C
Viviani, MA
Wu, T
Citation: Jh. Rex et al., Need for alternative trial designs and evaluation strategies for therapeutic studies of invasive mycoses, CLIN INF D, 33(1), 2001, pp. 95-106
Authors:
Uzun, O
Ascioglu, S
Anaissie, EJ
Rex, JH
Citation: O. Uzun et al., Risk factors and predictors of outcome in patients with cancer and breakthrough candidemia, CLIN INF D, 32(12), 2001, pp. 1713-1717
Authors:
Herbrecht, R
Letscher-Bru, V
Bowden, RA
Kusne, S
Anaissie, EJ
Graybill, JR
Noskin, GA
Oppenheim, BA
Andres, E
Pietrelli, LA
Citation: R. Herbrecht et al., Treatment of 21 cases of invasive mucormycosis with amphotericin B colloidal dispersion, EUR J CL M, 20(7), 2001, pp. 460-466
Authors:
Walsh, TJ
Goodman, JL
Pappas, P
Bekersky, I
Buell, DN
Roden, M
Barrett, J
Anaissie, EJ
Citation: Tj. Walsh et al., Safety, tolerance, and pharmacokinetics of high-dose liposomal amphotericin B (AmBisome) in patients infected with Aspergillus species and other filamentous fungi: Maximum tolerated dose study, ANTIM AG CH, 45(12), 2001, pp. 3487-3496
Authors:
Vartivarian, SE
Anaissie, EJ
Kiwan, EN
Papadakis, KA
Citation: Se. Vartivarian et al., The clinical spectrum of Stenotrophomonas (Xanthomonas) maltophilia respiratory infection, SEM RESP CR, 21(4), 2000, pp. 349-355
Authors:
McConnell, SA
Penzak, SR
Warmack, TS
Anaissie, EJ
Gubbins, PO
Citation: Sa. Mcconnell et al., Incidence of imipenem hypersensitivity reactions in febrile neutropenic bone marrow transplant patients with a history of penicillin allergy, CLIN INF D, 31(6), 2000, pp. 1512-1514
Authors:
Uzun, O
Anaissie, EJ
Citation: O. Uzun et Ej. Anaissie, Predictors of outcome in cancer patients with candidemia, ANN ONCOL, 11(12), 2000, pp. 1517-1521
Authors:
Penzak, SR
Gubbins, PO
Stratton, SL
Anaissie, EJ
Citation: Sr. Penzak et al., Investigation of an outbreak of gram-negative bacteremia among hematology-oncology outpatients, INFECT CONT, 21(9), 2000, pp. 597-599
Authors:
Uzun, O
Anaissie, EJ
Citation: O. Uzun et Ej. Anaissie, Outpatient therapy for febrile neutropenia: who, when and how?, J ANTIMICRO, 43(3), 1999, pp. 317-320
Authors:
Lozano-Chiu, M
Arikan, S
Paetznick, VL
Anaissie, EJ
Rex, JH
Citation: M. Lozano-chiu et al., Optimizing voriconazole susceptibility testing of Candida: Effects of incubation time, endpoint rule, species of Candida, and level of fluconazole susceptibility, J CLIN MICR, 37(9), 1999, pp. 2755-2759
Authors:
Lozano-Chiu, M
Arikan, S
Paetznick, VL
Anaissie, EJ
Loebenberg, D
Rex, JH
Citation: M. Lozano-chiu et al., Treatment of murine fusariosis with SCH 56592, ANTIM AG CH, 43(3), 1999, pp. 589-591
Risultati:
1-14
|